Genomics

Accelerating Medicines Partnership Alzheimer's Disease (AMP-AD) Diverse Cohorts Study

The Accelerating Medicines Partnership Alzheimer's Disease (AMP-AD) Diverse Cohorts Study is a cross-consortium project generating harmonized datasets from diverse human cohorts. It provides post-mortem multi-omic data from more than 850 individuals representing the spectrum of Alzheimer's disease phenotypes, with substantial representation of Black or African American and Hispanic or Latino individuals. Data were generated by research teams at Rush University, Emory University, Mayo Clinic, Columbia University, and the Icahn School of Medicine at Mount Sinai.

Listed for discovery. Access is provided by the original publisher under its terms.

Data coverage

The Accelerating Medicines Partnership Alzheimer's Disease (AMP-AD) Diverse Cohorts Study is a cross-consortium project generating harmonized datasets from diverse human cohorts. It provides post-mortem multi-omic data from more than 850 individuals representing the spectrum of Alzheimer's disease phenotypes, with substantial representation of Black or African American and Hispanic or Latino individuals. Data were generated by research teams at Rush University, Emory University, Mayo Clinic, Columbia University, and the Icahn School of Medicine at Mount Sinai.

Access & permitted use

Review the publisher’s documentation for availability, eligibility and permitted uses, including commercial analysis, model training and redistribution.

https://adknowledgeportal.synapse.org/Explore/Studies/DetailsPage/StudyDetails?Study=syn51732482Acknowledgement

Need help sourcing data?

Tell us your required fields, population, geography and time period. We can review suitable sources and licensing options.

Request sourcing help

Related data sources